NCT02660528 Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder Status TERMINATED Phase PHASE2
NCT02657980 The Effect of tDCS in Patients With Moderate to Severe Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT02646449 Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial Status COMPLETED Phase PHASE2
NCT02634177 Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD Status COMPLETED Phase NA
NCT02624102 Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression Status COMPLETED Phase PHASE3
NCT02616549 Multicomponent Yoga Intervention for Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT02615405 Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to Behaviour Status COMPLETED Phase NA
NCT02615119 Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa Status COMPLETED Phase NA
NCT02593643 Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression. Status COMPLETED Phase EARLY_PHASE1
NCT02586688 Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents Status COMPLETED Phase NA
NCT02579343 Adjunctive Treatment of Major Depression Utilizing Auricular Acupuncture Status COMPLETED Phase NA
NCT02562677 TNS for Treating Major Depressive Disorder in the Elderly Status UNKNOWN Phase PHASE1/PHASE2
NCT02553915 Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach Status COMPLETED Phase PHASE2/PHASE3